Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Steven M. Kawut, MD, MS

Professor of Medicine (Pulmonary, Allergy and Critical Care)
Attending, Pennsylvania Hospital, Philadelphia, PA
Attending, Hospital of the University of Pennsylvania
Attending, Penn Presbyterian Medical Center, Philadelphia, PA
Director, Pulmonary Vascular Disease Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Director, Pulmonary Vascular Disease Research Program, Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Member, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Department: Medicine

Contact information
Center for Clinical Epidemiology and Biostatistics
Perelman School of Medicine
9018 Gates Hall
3600 Spruce Street
Philadelphia, PA 19104-6021
Education:
AB (Biology)
Harvard College, Cambridge, MA, 1991.
MD (Medicine)
Yale School of Medicine, New Haven, CT, 1995.
MS (Clinical Epidemiology)
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2004.
Post-Graduate Training
Intern, Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1995-1996.
Resident, Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1996-1998.
Fellow, Pulmonary, Allergy, and Critical Care Division, Hospital of the University of Pennsylvania, Philadelphia, PA, 1998-2001.
Certifications
Board Certification in Internal Medicine, 2029.
Board Certification in Pulmonary, 2030.
Board Certification in Critical Care, 2031.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

The focus of my research group is the role of the pulmonary vasculature and right ventricular function in health and disease. We lead or contribute to epidemiologic studies and clinical trials of pulmonary arterial hypertension, hepatopulmonary syndrome, and lung transplantation. Members of our group also focus on congenital heart disease and pulmonary vascular disease in children.

Selected Publications

Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM: Sex and hemodynamics in pulmonary arterial hypertension. Eur Respir J 43(2): 523-30, February 2014.

Goncharov DA, Kudryashova TV, Ziai H, Ihida-Stansbury K, DeLisser H, Krymskaya VP, Tuder RM, Kawut SM, Goncharova EA. : mTORC2 coordinates pulmonary artery smooth muscle cell metabolism, proliferation and survival in pulmonary arterial hypertension. Circulation 129(8): 864-74, February 2014.

Whitman I, Patel VV, Soliman EZ, Bluemke DA, Praestgaard A, Jain A, Herrington D, Lima JAC, Kawut SM: Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: The MESA - Right Ventricle Study. JACC(13), 5435, September 2014.

Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JAC, Liu C-Y, Michos ED, Prince MR, Rabbani L, Rabinowitz D, Shimbo D, Shea S, Barr RG: Pulmonary hyperinflation and left ventricular mass: The Multi-Ethic Study of Atherosclerosis COPD Study. Circulation 127(14): 1503-11, August 2013.

Grau M, Graham Barr R, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, Kawut SM: Percent emphysema and right ventricular structure and function: The MESA Lung and MESA-RV Studies. Chest 144(1): 136-44, July 2013.

Fritz J, Blair C, Oudiz R, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM: Baseline and follow-up six minute walk distance and BNP predict 2-year mortalilty in pulmonary arterial hypertension. Chest 143(2): 315-23, February 2013.

Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. : Right ventricular structure is associated with the risk of heart failure and cardiovascular death: The MESA-Right Ventricle Study. Circulation 126(14): 1681-8, October 2012.

Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, Kawut SM, Halpern SD: Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest 141(1): 20-6, January 2012.

Gabler NM, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD: Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation 126(3): 349-56, Jul 2012.

back to top
Last updated: 11/09/2024
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration